Sulfonamides in dermatology

Clinics in Dermatology

Volumn 21, Issue 1, 2003, Pages 7-11

  Fuchs, Silke Marie ^a   Elsner, Peter ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; CEPHALOSPORIN; CLINDAMYCIN; COTRIMOXAZOLE; CYCLOSPORIN; DAPSONE; ERYTHROMYCIN; HYDANTOIN DERIVATIVE; MAFENIDE; METHOTREXATE; PENICILLIN G; PHENYTOIN; PYRIMETHAMINE; RIFAMPICIN; SALAZOSULFAPYRIDINE; STREPTOMYCIN; SULFACETAMIDE; SULFADIAZINE; SULFADIAZINE SILVER; SULFADOXINE; SULFAFURAZOLE; SULFALENE; SULFAMETHOXAZOLE; SULFAPHENAZOLE; SULFONAMIDE; SULFONYLUREA DERIVATIVE; TOLBUTAMIDE; TRIMETHOPRIM; WARFARIN;

ACNE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; APLASTIC ANEMIA; ARTICLE; ATOPIC DERMATITIS; BACTERIAL GROWTH; BACTERIAL INFECTION; BLOOD DYSCRASIA; BONE MARROW SUPPRESSION; BURN INFECTION; CHLAMYDIASIS; CONTACT ALLERGY; CRYSTALLURIA; DRUG ABSORPTION; DRUG ACTIVITY; DRUG BINDING; DRUG BINDING SITE; DRUG EFFECT; DRUG EFFICACY; DRUG EXCRETION; DRUG FEVER; DRUG MECHANISM; DRUG SOLUBILITY; DRUG STRUCTURE; GROWTH INHIBITION; HEMOLYSIS; HEMOLYTIC ANEMIA; HUMAN; KERNICTERUS; LEUKOPENIA; LIVER METABOLISM; LUPUS ERYTHEMATOSUS; NEUTROPENIA; OTITIS MEDIA; PHOTODERMATOSIS; PRIORITY JOURNAL; RASH; RHINITIS; SIDE EFFECT; SINUSITIS; STEVENS JOHNSON SYNDROME; THROMBOCYTOPENIA; TOXIC EPIDERMAL NECROLYSIS; ULCUS MOLLE; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; URTICARIA; VASCULITIS;

EID: 0037216042     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(02)00326-7     Document Type: Article

References (53)

1. Sulzberger M.B. Acrodermatitis continua pustulosa (Hallopeau) treated with sulfapyridine. Arch Dermatol Syphilol. 40:1939;1019-1021.
2. Verg E. Meilensteine, Bayer AG, Leverkusen 1988, 272-276.
3. Mutschler: Arzeneimittelwirkungen. Lehrbuch der Pharmakologie und Toxikologie. Wissenschaftliche Verlagsgesellschaft Stuttgart, 2001;8 Aufl:816-819.
4. Goodman and Gilman's, The pharmacological basis of therapeutics, 9th ed. New York: Pergamon Press, 1996;1079-86.
5. The Merck Manual, Sec. 13, Ch. 153, Antibacterial Drugs, Whitehouse Station, NJ: Merck Research Laboratories, 2002.
6. Rogers R.S., Muller S.A. Treatment of actinomycetoma with dapsone. Arch Dermatol. 109:1974;529-534.
7. Alexander J.O. Dermatitis herpetiformis. Rook A. Major problems in dermatology. 1975;289-295 WB Saunders Co, Philadelphia.
8. Millikan L.E., Harell E.R. Drug reactions to the sulfones. Arch Dermatol. 102:1970;220-224.
9. Pearon G., Lang J.R. Sulfones and sulfonamides in dermatology today. J Am Acad Dermatol. 1:1979;479-492.
10. Israili Z.H., Cucinell S.A., Vaught J., et al. Studies of the metabolism of dapsone in man and experimental animals formation of N-hydroxy metabolites . J Pharmacol Exp Ther. 187:1973;138-151.
11. Simon C, Stille W. Antibiotika-Therapie in Klinik und Praxis. Schattauer, Stuttgart 2000;10 Aufl:222-233.
12. Korting H.C., Abeck D., Grimm W., et al. Heutige in-vitro-Empfindlichkeit von Hautbakterien gegenüber unterschiedlichen Chemotherapeutika. Quantitative Ergebnisse des Mikrodilutionstests. Akt Dermatol. 16:1990;27-31.
13. Huovinen P., Sundström L., Swedberg G., Sköld O. Trimethoprim and sulfonamide resistance. Antimicrob Ag Chemother. 39:1995;279-289.
14. McRae. Long-term sulfamethoxazole-trimethoprim in Wegners granulomatosis. Arch Otolaryng. 119:1993;103-105.
15. Park. Pneumocystis carinii infection in the middle ear. Arch Otolaryng. 118:1992;269-270.
16. Sanz de Galdeano C., Aguirre A., Oleaga J.M., et al. Allergic contact dermatitis from topical mafenide. Contact Dermatol. 28:1993;249.
17. Rudzko E., Rebandel P. Primary sensitivity to sulphonamide and secondary sensitization to aromatic amines. Contact Dermatol. 17:1987;49.
18. Angelini G., Meneghini C.L. Oral Tests in contact allergy to para-amino compounds. Cont Dermatol. 7:1981;311-314.
19. Uter W., Geier J., Fuchs T., et al. Das Epikutantest-Screening mit Parastoffen. Dermatol Beruf Umwelt. 49:2001;42.
20. Valsecchi R., Foiadelli L., Cainelli T. Is silver sulfadiazine a sensitizer? Contact Dermatol. 15:1986;45.
21. Hartmann A. Chlamydia infections in dermatology. Z Hautkr. 64:(15):1989;388-391 -2.
22. Kumar B., Sharma V.K., Bakaya V. Sulphaphenazole, streptomycin and sulphaphenazole combination, trimethromprim, and erythromycin in the treatment of chancroid. Genitourin Med. 66:1990;105-107.
23. Delaporte E., Catteau B., Sabbagh N., et al. Treatment of discoid lupus erythematosus with sulfasalazine 11 cases . Ann Dermatol Venereol. 124:1997;151-156.
24. Breneman D.L., Ariano M.C. Successful treatment of acne vulgaris in women with a new topical sodium sulfacetamide/sulfur lotion. Int J Dermatol. 32:1993;365-367.
25. Simpson N. Antibiotics in acne time for a rethink . Br J Dermatol. 144:2001;225-227. (Editorial).
26. Schnuch A. Haben Sulfonamide noch ihren Platz in der Dermatologie? Hautarzt. 53:2002;163-166.
27. Boudghene-Stambouli O., Merad-Boudia A. Chancroid in Algeria the status of this sexually transmitted disease in 1995 . Bull Soc Pathol Exot. 90:1997;78-80.
28. McCabe R.E., Remington J.S. Toxoplasma gondii. Mandell G.L., Douglas R.G. Jr, Bennett J.F. Principles and practice of infectious diseases. 3rd ed:1990;2090-2103 Churchill Livingstone, Inc, New York.
29. Breit R., Seifert P. Mafenide-still an allergen of importance? Frosch P.J., Dooms-Goossens A., Lachapelle J.M., et al. Current topics in contact dermatitis. 1989;222-225 Springer, New York.
30. Pruitt B.A. Opportunistic infections in burn patients diagnosis and treatment. Root R., Trunkey R., Sande M.A. New surgical and medical approaches in infectious diseases. 1987;245-261 Churchill Livingstone, Inc, New York.
31. De Rave L., Song M., Van Maldergem L. Adverse cutaneous drug reactions in AIDS. Br J Dermatol. 119:1988;521-523.
32. Koch-Weser J., Hodel C., Leimer R., et al. Adverse reactions to pyrimethamine/sulfadoxine. Lancet. ii:1982;1459.
33. Brumfitt W., Hamilton-Miller J.M. Combinations of sulphonamides with diaminopyrimidines how, when and why? J Chemother. 7:1995;136-139.
34. Fernandez J.C., Gamoa P., Jauregui I., et al. Concomitant sensitization to enoxolone and mafenide in a topical medicament. Contact Dermatol. 27:1992;262.
35. McKenna S.R., Latensser B.A., Jones L.M., et al. Serious silver sulfadiazine and mafenide acetate dermatitis. Burns. 125:1995;1069-1073.
36. Husian Z. Sulcindac-induced Stevens-Johnson syndrome report of 3 cases . J Rheumatol. 8:1981;176-178.
37. Kikuchi S., Okazaki T. Stevens-Johnson syndrome due to co-trimoxazole. Lancet. II:1978;580.
38. Potter RC. Stevens-Johnson syndrome: immunogenetics, susceptibility, screening and application to ro 3f1-3948 and other drugs. R& D Memorandum Roche 1986, No 12116.
39. Aberer W., Stingl G., Wolff K. Stevens-Johnson-Syndrom und toxische epidermale Nekrolyse nach Sulfonamideinnahme. Der Hautarzt. 33:1982;484-490.
40. Margolis D.J., Bondi E.E. Toxic epidermal necrolysis associated with sulfonamides. Int J Dermatol. 29:1990;153.
41. Cohen A.D., Friger M., Sarov B., et al. Which intercurrent infections are associated with maculopapular cutaneous drug reactions? A case-control study. Int J Dermatol. 40:2001;41-44.
42. Björnberg A. Fifteen cases of toxic epidermal necrolysis (Lyell). Acta Derm Venereol (Stockh). 53:1973;149-152.
43. Schöpf E. Skin reactions to co-trimoxazole. Infection. 15:(Suppl 5):1987;254-258.
44. Brettle R.P., Gray J.A., Sangster G., et al. The mucocutaneous syndroms - Erythema multiforme, Stevens-Johnson and Ectodermosis erosiva pluriorificialis. J Infect. 4:1982;149-160.
45. Dürst U.N., Müller E., Pfister T., et al. Toxische epidermale Nekrolyse (Lyell-Syndrom). Schweiz. Med. Wochenschr. 116:1986;713-720.
46. Ebel V., Baumann R. Czechanowski. 5 Fälle von medikamenteninduziertem Lyell-Syndrom. Klin Wochenschr. 63:(Suppl 4):1985;163-164.
47. Kint A., Geerhs M.L., de Weert J. Le Syndrome de Lyell. Dermatologica. 163:1981;433-454.
48. Mockenhaupt M., Schöpf E. Epidemiology of drug induced severe skin reactions. Semin Cutan Med Surg. 15:1996;236-243.
49. Mafenide acetate cream a review . Drugs. 1:1971;434-460.
50. Shipley D., Ormerod A.D. Drug-induced Urticaria. Recognition and Treatment. Am J Clin Dermatol. 2:2001;151-158.
51. Gould J.W., Mercurio M.G., Elmets C.A. Cutaneous photosensitivity diseases induced by exogeneous agents. J Am Acad Dermatol. 33:1995;551-573.
52. Gottschalk H.R., Stone O.J. Stevens Johnsons Syndrome from ophtalmic sulfonamide. Arch Dermatol. 112:1976;513-514.
53. Yaffee H.S., Dressler D.P. Topical application of mafenide acetate its association with erythema multiforme and cutaneous reactions . Arch Dermatol. 100:1969;277-281.